NGeneBio Co., Ltd. Logo

NGeneBio Co., Ltd.

Develops NGS-based molecular diagnostic products and software for oncology.

354200 | KO

Overview

Corporate Details

ISIN(s):
KR7354200008
LEI:
Country:
South Korea
Address:
서울특별시 구로구 디지털로 288 303호. 304호. 305호. 306호. 307호. 제지1층 제비 127호, 제지1층 제비 1, 구로구

Description

NGeneBio Co., Ltd. is a precision diagnostics company specializing in Next-Generation Sequencing (NGS) technology. The company develops and commercializes molecular diagnostic products, including in-vitro diagnostic (IVD) and companion diagnostic (CDx) solutions. Its primary focus is on oncology, offering NGS panels for the analysis of solid tumors and hematologic malignancies. Complementing its diagnostic assays, NGeneBio provides integrated bioinformatics software for comprehensive data analysis and interpretation. The company's portfolio also includes liquid biopsy technologies and personal genetic testing services, all aimed at providing precise genomic information to guide clinical decision-making.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-01 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-09-01 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-08-19 00:00
주식등의대량보유상황보고서(일반)
Korean 125.6 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 2.2 MB
2025-08-01 00:00
주식등의대량보유상황보고서(일반)
Korean 124.6 KB
2025-08-01 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-08-01 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-07-04 00:00
주식등의대량보유상황보고서(일반)
Korean 146.8 KB
2025-06-30 00:00
대표이사변경
Korean 10.7 KB
2025-06-27 00:00
증권발행결과(자율공시)
Korean 5.6 KB
2025-06-27 00:00
[기재정정]주요사항보고서(유상증자결정)
Korean 60.8 KB
2025-06-27 00:00
최대주주인명목회사·조합등의최대주주변경
Korean 15.0 KB
2025-06-26 00:00
임시주주총회결과
Korean 21.7 KB
2025-06-26 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 15.0 KB
2025-06-20 00:00
주식등의대량보유상황보고서(약식)
Korean 102.7 KB

Automate Your Workflow. Get a real-time feed of all NGeneBio Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NGeneBio Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NGeneBio Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.